Veracyte, Inc. (VCYT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Veracyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.456 Good day and thank you for standing by. Welcome to the Verisight fourth quarter 2025 00:00:04.456 -- 00:00:07.399 financial results webcast. 00:00:07.399 -- 00:00:10.983 At this time, all participants are in a listen-only mode. 00:00:10.983 -- 00:00:14.887 After the speaker's presentation, there will be a question and answer session. 00:00:14.887 -- 00:00:18.772 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:18.772 -- 00:00:22.996 You will then hear an automated message advising your hand is raised. 00:00:22.996 -- 00:00:26.540 To withdraw your question, please press star 1-1 again. 00:00:26.540 -- 00:00:30.018 Please be advised that today's conference is being recorded. 00:00:30.018 -- 00:00:34.304 I would now like to hand the conference over to your first speaker today, Shayla Gorman, 00:00:34.304 -- 00:00:39.049 Senior Director, Investor Relations. Please go ahead. 00:00:39.793 -- 00:00:43.819 Good afternoon, everyone, and thank you for joining us today for a discussion of our 00:00:43.819 -- 00:00:48.285 fourth quarter and full year 2025 financial results. 00:00:48.285 -- 00:00:53.393 With me today are Mark Stathley, Verisight's Chief Executive Officer, and Rebecca Chambers, 00:00:53.393 -- 00:00:58.408 our Chief Financial Officer. Dr. John Light, our Chief Commercial Officer, and Dr. 00:00:58.408 -- 00:01:04.558 Phil Febo, our Chief Medical and Scientific Officer, will join us for Q&A. 00:01:04.558 -- 00:01:08.884 Verisight issued a press release earlier this afternoon detailing our fourth quarter 00:01:08.884 -- 00:01:14.172 and full year 2025 financial results. This release and a copy of the presentation 00:01:14.172 -- 00:01:19.319 we will review during the call today are availa...